ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,354.03
1.18%
Dow Jones
38,807.33
0.25%
US Dollar vs MXN
17.4669
-0.29%
Brent Oil
78.705
0.18%
Bitcoin
70,929.90
-0.21%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Relmada Therapeutics Inc (RLMD)

  7. Relmada Therapeutics Inc (RLMD) Noticias

RLMD

Relmada Therapeutics (RLMD)

Relmada Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:RLMD
FechaHoraFuenteTítuloSímboloCompañía
29/05/202420:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLMDRelmada Therapeutics Inc
08/05/202415:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RLMDRelmada Therapeutics Inc
19/03/202406:27IH Market NewsUS Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices RetreatNASDAQ:RLMDRelmada Therapeutics Inc
20/02/202416:55Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RLMDRelmada Therapeutics Inc
14/02/202407:53Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:RLMDRelmada Therapeutics Inc
11/01/202415:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLMDRelmada Therapeutics Inc
21/06/202316:01Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:RLMDRelmada Therapeutics Inc
30/05/202316:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RLMDRelmada Therapeutics Inc
25/05/202315:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RLMDRelmada Therapeutics Inc
12/05/202304:45PR Newswire (US)RLMD FRAUD ALERT: Jakubowitz Law is Investigating Relmada Therapeutics, Inc. in Connection with Potential Violations of Federal Securities LawsNASDAQ:RLMDRelmada Therapeutics Inc
10/05/202304:45PR Newswire (US)INVESTIGATION ALERT: The Gross Law Firm Notifies Shareholders of Relmada Therapeutics, Inc. of an Investigation and Potential Class Action Lawsuit - (NYSE: RLMD)NASDAQ:RLMDRelmada Therapeutics Inc
31/03/202308:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:RLMDRelmada Therapeutics Inc
14/02/202316:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RLMDRelmada Therapeutics Inc
09/02/202310:47Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:RLMDRelmada Therapeutics Inc
02/02/202316:02Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:RLMDRelmada Therapeutics Inc
07/12/202221:15TipRanksMizuho Securities Sticks to Their Buy Rating for Relmada Therapeutics (RLMD)NASDAQ:RLMDRelmada Therapeutics Inc
11/11/202205:55TipRanksRelmada Therapeutics (RLMD) Gets a Buy from Mizuho SecuritiesNASDAQ:RLMDRelmada Therapeutics Inc
10/11/202215:09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RLMDRelmada Therapeutics Inc
16/10/202223:51TipRanksAnalysts’ Top Healthcare Picks: InMode (INMD), Avidity Biosciences (RNA)NASDAQ:RLMDRelmada Therapeutics Inc
13/10/202211:36TipRanksRelmada Nosedives after Depression Therapy Fails in Phase 3NASDAQ:RLMDRelmada Therapeutics Inc
13/10/202206:45TipRanksMizuho Securities Keeps Their Buy Rating on Relmada Therapeutics (RLMD)NASDAQ:RLMDRelmada Therapeutics Inc
07/10/202212:55TipRanksRelmada Therapeutics put volume heavy and directionally bearishNASDAQ:RLMDRelmada Therapeutics Inc
16/08/202203:45TipRanksSVB Securities Reaffirms Their Buy Rating on Relmada Therapeutics (RLMD)NASDAQ:RLMDRelmada Therapeutics Inc
09/08/202208:21Dow Jones NewsRelmada Gets FDA Fast-Track Designation for REL-1017 as MDD MonotherapyNASDAQ:RLMDRelmada Therapeutics Inc
08/05/202219:45TipRanksMizuho Securities Reaffirms Their Buy Rating on Relmada Therapeutics (RLMD)NASDAQ:RLMDRelmada Therapeutics Inc
08/05/202210:11TipRanksRelmada Therapeutics (RLMD) Gets a Buy Rating from SVB SecuritiesNASDAQ:RLMDRelmada Therapeutics Inc
07/04/202216:14Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:RLMDRelmada Therapeutics Inc
28/03/202219:36TipRanksRelmada Therapeutics (RLMD) Gets a Buy Rating from Mizuho SecuritiesNASDAQ:RLMDRelmada Therapeutics Inc
25/03/202206:54Edgar (US Regulatory)Annual Report (10-k)NASDAQ:RLMDRelmada Therapeutics Inc
29/12/202108:36TipRanksAnalysts’ Top Healthcare Picks: LHC Group (LHCG), BridgeBio Pharma (BBIO)NASDAQ:RLMDRelmada Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:RLMD

Su Consulta Reciente

NASDAQ
AAZTHXX
Bofa Finance Llc Issuer ...
EU
SMC
SPDR MSCI Europe Small C...
BOV
HONB34Q
Honeywell Life Care Solu...
LSE
UB01
Ubsetf E50gba
ASX
AUN
Aurumin
EU
AMPAE
Metropole AixMarseille P...
LSE
QK93
Morg.st.b.v 25
BIT
P20J27
NLBNPIT20J27 20351221 11...
USOTC
ABLAF
Abalance (CE)
USOTC
MITSY
Mitsui (PK)
BIT
P1Z5E3
NLBNPIT1Z5E3 20991231 10...
BIT
P20EW7
NLBNPIT20EW7 20351221 95...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados